Concept

Results of Anhui Zhifei Longcom and the Chinese Academy of Medical Sciences Vaccine

  • 97% of trial participants developed high levels of neutralizing antibodies which is an indicator of immunity to the SARS-COV2 virus
  • Antibody levels in the participants were two times the amount compared to a sample of 89 people who had COVID-19 and recovered from it.

0

1

Updated 2020-12-03

Tags

SARS-CoV-2 (COVID-19)

Biomedical Sciences